NURIX THERAPEUTICS, INC. (NRIX) Financial Statements
NURIX THERAPEUTICS, INC. (NRIX) files with the U.S. Securities and Exchange Commission under CIK 0001549595. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $83.98 million
- Net Income
- -$264.46 million
- Total Assets
- $688.13 million
- Net Cash from Operations
- -$249.47 million
Fiscal year ended Nov 30, 2025. Latest periodic SEC filing: Oct 13, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for NRIX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History